Last $1.15 USD
Change Today +0.03 / 2.68%
Volume 7.1K
ULUR On Other Exchanges
As of 8:10 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

uluru inc (ULUR) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/14 - $1.83
52 Week Low
09/27/13 - $0.37
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ULURU INC (ULUR)

Related News

No related news articles were found.

uluru inc (ULUR) Related Businessweek News

No Related Businessweek News Found

uluru inc (ULUR) Details

ULURU Inc., a specialty pharmaceutical company, is engaged in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company develops its products based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as non-healing surgical, trauma, and chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; Aphthasol for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company’s OraDisc products are also used for various dental applications. ULURU Inc. is headquartered in Addison, Texas.

7 Employees
Last Reported Date: 03/31/14

uluru inc (ULUR) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $210.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $200.0K
Vice President of Polymer Drug Delivery
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2013.

uluru inc (ULUR) Key Developments

ULURU Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

ULURU Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the period, the company’s net loss allocable to common share holders was $691,460 or $0.03 per basic and diluted share compared with a net loss of $668,611 or $0.06 per and diluted share for the same period last year. Revenues for the first quarter of 2014 were $101,980, equivalent to the first quarter of 2013. Operating loss was $773,445 against $547,369 a year ago. Loss before income tax was $691,460 against $656,590 a year ago.

ULURU Inc., Q1 2014 Earnings Call, May 16, 2014

ULURU Inc., Q1 2014 Earnings Call, May 16, 2014

ULURU Inc., Annual General Meeting, Jun 05, 2014

ULURU Inc., Annual General Meeting, Jun 05, 2014., at 10:00 Central Standard Time. Location: 4452 Beltway Drive. Agenda: To elect four members to the Board of Directors to hold office until the annual meeting for 2015, and until their successors are elected and qualified; to ratify the appointment of Lane Gorman Trubitt, PLLC as independent registered public accounting firm for the fiscal year ending December 31, 2014; to approve a proposal to amend the company's 2006 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance; and to transact such other business as may properly come before the meeting or any adjournments thereof.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ULUR:US $1.15 USD +0.03

ULUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $145.12 USD -0.01
Smith & Nephew PLC 1,055 GBp -2.00
View Industry Companies

Industry Analysis


Industry Average

Valuation ULUR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 66.5x
Price/Book 8.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 72.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULURU INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at